1 Introduction Diabetic kidney disease (DKD) is a major diabetes-related microvascular disorder and currently accounts for a substantial proportion of end-stage renal disease (ESRD) worldwide [1, 2]. Approximately 40% of individuals with diabetes progress to ESRD [3], imposing a substantial economic burden worldwide. DKD pathogenesis is intricate and variable; accordingly, new DKD treatments are urgently required.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile